A recent study highlighted the prevalence of recreational drug use among American teenagers, revealing that an estimated 2.9 million Americans under 18 have used marijuana in recent years.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

When prescribing opioids for acute pain, physicians should be attentive to a patient’s individual risk factors, according to ...

Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use ...

More New Yorkers received scripts for buprenorphine, a med used to treat opioid addiction, amid fight against record-high ...

A new congressionally mandated report examines how opioid and benzodiazepine prescribing between 2007 and 2019 impacted ...

including heroin and prescription pain relievers like Vicodin and Oxycontin, skyrocketed 41% from 2022 to 2023. After weed, opioids ranked the second most commonly misused drug for teens with ...

NSDUH only queried opioid misusers about opioid use disorder symptoms. After they changed the protocol and asked all ...

The program establishes five drop box locations across the U.S. Virgin Islands—two in St. Croix, two in St. Thomas, and one ...

After nearly a decade of almost year-over-year increases in overdose deaths, the tide may finally be turning in Philadelphia.

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.